Impact of a PERsonalized CAse MAnagement Program for the Follow-up of Moderate and Severe aSTHma Patients on Exacerbations, Health Resource Use and Asthma Control: PERCASTHMA STUDY
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
MurciaSalud
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age ≥ 18 years.
Previous diagnosis of bronchial asthma according to GEMA 5.4 criteria.
• Follow-up for at least 6 months in an asthma unit and absence of relevant uncontrolled comorbidities.
Classified as moderate or severe asthma according to therapeutic step at the beginning of the study, as defined by GEMA 5.4.
Signed informed consent form.
You may not be if
Simultaneous presence of other diseases that may simulate asthma symptoms (COPD, left heart failure, functional dyspnea/hyperventilation syndrome, inducible laryngeal obstruction...).
Severe psychosocial problems or any other clinical situation that prevents the signature of the informed consent and/or the follow-up proposed in the study.
Lack of minimum technological knowledge for the use of monitoring tools.
Clareo Health | Impact of a PERsonalized CAse MAnagement Program for the Follow-up of Moderate and Severe aSTHma Patients on Exacerbations, Health Resource Use and Asthma Control: PERCASTHMA STUDY
